Published in Acta Radiol on November 01, 2001
Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir. J Clin Invest (2013) 0.90
Contrast-enhanced MR imaging in the diagnosis and preservation of cardiac viability. Acta Radiol (2001) 0.80
First clinical experience with the magnetic resonance imaging contrast agent and superoxide dismutase mimetic mangafodipir as an adjunct in cancer chemotherapy-a translational study. Transl Oncol (2012) 0.79
Effects of MnDPDP and ICRF-187 on Doxorubicin-Induced Cardiotoxicity and Anticancer Activity. Transl Oncol (2012) 0.78
Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat. PLoS One (2012) 0.78
Superior therapeutic index of calmangafodipir in comparison to mangafodipir as a chemotherapy adjunct. Transl Oncol (2012) 0.76
Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet (2000) 5.61
Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med (1997) 5.35
Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature (1983) 5.14
Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol (1998) 4.48
Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia (2007) 2.96
Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr (2000) 2.53
The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr (2000) 2.45
Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr (1998) 2.41
Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet (1995) 2.36
Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA (1995) 2.31
Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation (1998) 2.31
Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci (2001) 2.13
Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem (1993) 2.07
Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem (1993) 2.01
Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med (1989) 1.85
Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr (2001) 1.84
Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants. Arzneimittelforschung (1983) 1.82
Serum total homocysteine and coronary heart disease. Int J Epidemiol (1995) 1.79
Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67
Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. Am J Clin Nutr (1997) 1.58
Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552). Arzneimittelforschung (1980) 1.57
A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis (1998) 1.50
Cardiac fibrinolytic capacity is markedly increased after brief periods of local myocardial ischemia, but declines following successive periods in anesthetized pigs. J Thromb Haemost (2005) 1.48
Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr (1996) 1.47
Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM (2006) 1.46
Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients. Clin Pharmacol Ther (2007) 1.43
Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology (2008) 1.39
Contributions of a transient outward current to repolarization in human atrium. Am J Physiol (1989) 1.36
Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int (1999) 1.31
Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol (2000) 1.30
Dihydropyridine receptor in rat brain labeled with [3H]nimodipine. Proc Natl Acad Sci U S A (1983) 1.29
Respiration-synchronous fluctuations in stroke volume, heart rate and arterial pressure in humans. J Physiol (1993) 1.29
Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication. Acta Psychiatr Scand (2006) 1.27
Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines. Br J Pharmacol (2008) 1.26
The Glostrup population studies. Collection of epidemiologic tables. Reference values for use in cardiovascular population studies. Scand J Soc Med Suppl (1981) 1.26
Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation (2000) 1.23
Total homocysteine and cardiovascular disease. J Intern Med (1999) 1.23
Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project. Circulation (2001) 1.20
Modulation of calcium channel function by drugs. Life Sci (1985) 1.20
The status of local smoking regulations in North Carolina following a state preemption bill. JAMA (1995) 1.17
Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. J Cardiovasc Risk (2001) 1.17
The effects of the dihydropyridine Bay K 8644 in guinea-pig isolated trachealis. Br J Pharmacol (1985) 1.17
Uptake kinetics and ion requirements for extraneuronal uptake of noradrenaline by arterial smooth muscle and collagen. Br J Pharmacol (1973) 1.16
Fluctuations in blood flow to acral skin in humans: connection with heart rate and blood pressure variability. J Physiol (1993) 1.16
Biological and environmental determinants of plasma homocysteine. Semin Thromb Hemost (2000) 1.13
Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet (1997) 1.13
Signs of impaired cognitive function in adolescents with marginal cobalamin status. Am J Clin Nutr (2000) 1.12
Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol (2000) 1.11
High performance liquid chromatography: a rapid isocratic method for determination of creatine compounds and adenine nucleotides in myocardial tissue. J Mol Cell Cardiol (1986) 1.09
Myocardial protection during ischemic cardiac arrest. A possible hazard with calcium-free cardioplegic infusates. J Thorac Cardiovasc Surg (1977) 1.09
Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study. J Clin Invest (1996) 1.09
The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle. Arzneimittelforschung (1982) 1.06
Effect of pyocyanin and 1-hydroxyphenazine on in vivo tracheal mucus velocity. J Appl Physiol (1985) (1989) 1.04
Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol (1997) 1.02
Determinants of cobalamin status in newborns. Pediatrics (2001) 1.01
Primary care in a penal institution. A study of health care problems encountered. Med Care (1975) 1.01
Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clin Chem (1999) 1.01
Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol (2000) 1.00
Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate. Clin Pharmacol Ther (1991) 1.00
Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes. Stem Cell Res (2012) 1.00
Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease. Scand J Clin Lab Invest (1997) 1.00
Plasma vitamin B12 status and cerebral white-matter lesions. J Neurol Neurosurg Psychiatry (2008) 0.99
Cold cardioplegia or continuous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically. J Thorac Cardiovasc Surg (1977) 0.98
Magnesium and reperfusion of ischemic rat heart as assessed by 31P-NMR. Am J Physiol (1989) 0.98
Class III antiarrhythmic action linked with positive inotropy: effects of the d- and l-isomer of sotalol on isolated rat atria at threshold and suprathreshold stimulation. Pharmacol Toxicol (1988) 0.97
Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg (1994) 0.97
Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered? Eur J Clin Nutr (2001) 0.97
Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action. Acta Neurochir (Wien) (1982) 0.96
Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol (1990) 0.96
Radioenzymic determination of homocysteine in plasma and urine. Clin Chem (1985) 0.96
The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis (1997) 0.95
The Hordaland Homocysteine Studies. Lipids (2001) 0.95
Experimental hypothermia: effects of core cooling and rewarming on hemodynamics, coronary blood flow, and myocardial metabolism in dogs. Anesth Analg (1994) 0.95
Impaired glucose tolerance and diabetes mellitus in elderly subjects. Diabetes Care (1987) 0.94
Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart (1999) 0.94
Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. Am J Clin Nutr (1999) 0.94
Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. J Intern Med (2010) 0.94
A heterodyne ultrasound blood velocity meter. Med Biol Eng Comput (1981) 0.93
Four common mutations of the cystathionine beta-synthase gene detected by multiplex PCR and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem (1999) 0.92
Oxygen delivery and return of spontaneous circulation with ventilation:compression ratio 2:30 versus chest compressions only CPR in pigs. Resuscitation (2004) 0.92
Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study. J Neurol Neurosurg Psychiatry (2006) 0.91
Modulation of calcium ion influx by the 1,4-dihydropyridines nifedipine and BAY K 8644. J Cardiovasc Pharmacol (1985) 0.91
Recurrent nerve/ansa cervicalis nerve anastomosis: a treatment alternative in unilateral recurrent nerve paralysis. Acta Otolaryngol (1992) 0.91
Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int (1997) 0.91
Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients. Eur J Clin Pharmacol (2008) 0.90
Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clin Chem (1998) 0.90
Electrophysiological effects of melperone in the dog heart in situ - a new antiarrhythmic drug. Cardiovasc Res (1981) 0.90
Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo. Ann Thorac Surg (1997) 0.89
Short-term cardiovascular responses to a step decrease in peripheral conductance in humans. Am J Physiol (1994) 0.89
Methylmalonic acid and homocysteine in plasma as indicators of functional cobalamin deficiency in infants on macrobiotic diets. Pediatr Res (1994) 0.89
Ultrastructural studies of intercalated disc separations in the rat heart during the calcium paradox. Res Exp Med (Berl) (1985) 0.89
Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India. Eur J Clin Nutr (2010) 0.89
A pilot study quantifying the shape of tidal breathing waveforms using centroids in health and COPD. J Clin Monit Comput (2013) 0.89
Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. Eur J Clin Nutr (2005) 0.89
Cardiac contractile function and electrolyte regulation during hyperosmolal stress: an experimental study in the isolated rabbit heart. Pharmacol Toxicol (1999) 0.88
Cardiac electrophysiology, arrhythmogenic mechanisms and roentgen contrast media. Acta Radiol Suppl (1995) 0.88
The amino-acid sequence of the variable region of a carbohydrate-containing amyloid fibril protein EPS (immunoglobulin light chain, type lambda). Biol Chem Hoppe Seyler (1985) 0.88
The Electro-Mechanical window: a risk marker for Torsade de Pointes in a canine model of drug induced arrhythmias. Br J Pharmacol (2010) 0.88